The invention provides compounds of formula I [INSERT CHEMICAL STRUCTURE HERE] (I) and pharmaceutically acceptable salts thereof. The formula I thiazolyl compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.
-
Page/Page column 20
(2010/03/31)
Imidazole based kinase inhibitors
The present invention provides compounds having Formula I and their use for the treatment of cancer.
-
Page/Page column 9
(2008/06/13)
Benzimidazole C-2 heterocycles as kinase inhibitors
Benzimidazole derivatives having the general formula I are provided. These compounds are useful as tyrosine kinase inhibitors, especially for the treatment of cancer.
-
Page/Page column 12
(2010/02/11)
NOVEL TYROSINE KINASE INHIBITORS
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The formula (I) compounds inhibit tyrosine kinase enzymes thereby making them useful as anti-cancer agents.
-
Page 35
(2008/06/13)
Novel tyrosine kinase inhibitors
The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase enzymes thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases which can be treated by inhibiting tyrosine kinase enzymes.